NIFTY
80.75  0.75%
 10821.85
S&P BSE SENSEX
257.21  0.73%
 35689.6
Aurobindo Pharma Ltd.
NSE : AUROPHARMA BSE : 524804 ISIN code : INE406A01037
on 22-Jun-2018
NSE
2.55    0.42%
Rs. 611.10
 
Days Low
Rs. 596.8
Days High
Rs. 614.05

Open Rs. 610.5
 
52 week Low
Rs. 527.05
52 week High
Rs.808.95
 
 
Bid :                 611.45 (170)
Offer :        0.00 (0)
BSE
Rs.611.45
2.9    0.48%
on 22-Jun-2018
BSE
2.9    0.48%
Rs. 611.45
 
Days Low
Rs. 596.3
Days High
Rs. 614.5

Open Rs. 609.4
 
52 week Low
Rs. 527
52 week High
Rs.809.45
 
 
Bid :                 611.45 (170)
Offer :        0.00 (0)
NSE
Rs.611.10
2.55    0.42%
 
 
Last Price (Rs.)  611.45 Value  78056889.00
Net Change (Rs.)  2.90 Best Buy  611.45
Volume  128819 Best Sell  0.00
Prev.Close (Rs.)  608.55 Best Quantity  170
Open (Rs.)  610.50 Sell Quantity  0
High (Rs.)  614.05 52-Week High (Rs.)  808.95
Low (Rs.)  596.80 52-Week Low (Rs.)  527.05
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  358253.21
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Share Capital585.90 585.20 292.00 
Currents Investments0.20 0.20 196.40 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 576.30 1382731 82.40 0.00 0.35
Cipla 614.00 494387 175.28 50.67 0.49
Piramal Enterprises 2602.35 469965 1186.24 57.81 0.96
Cadila Healthcare 410.55 420298 75.66 63.51 0.85
Lupin 904.90 409126 349.13 13.01 0.55
 
Mutual Funds Holdings
Scheme Name% HoldNo.Shares
HDFC Prudence Fund(G) 1.27 8345200
HDFC Balanced Fund(G) 1.80 6582000
HDFC Equity Fund(G) 1.71 6247526
Aditya Birla SL Frontline Equity Fund(G) 1.58 5490981
HDFC Top 100 Fund(G) 1.41 3632450
 
Quarterly Result
(Rs .in millions)Mar 2018Dec 2017Sep 2017
Net Sales23547.2026862.8030738.60
Operating Profit4842.406980.9010680.70
PBDT4668.306848.8010560.50
Net Profit3082.904443.207528.30
More> 
 
Company News
6/20/2018 12:00:00 AM
Announcement under Regulation 30 (LODR)-Newspaper Publication
6/18/2018 12:00:00 AM
Aurobindo Pharma informs about audited financial results
6/8/2018 12:00:00 AM
Aurobindo Pharma receives USFDA’s approval for Omeprazole DR Tablets O...
More>
 
Ratios
   Earnings Per Share (Rs)29.13 
   Book NAV/Share(Rs)143.99 
   PAT Margin (%)17.45 
   Asset Turnover(x)0.76 
   PER(x)23.18 
   Yield(%)0.37 
   EV/Core EBITDA(x)16.96 
   M Cap / Sales4.12 
   Net Sales Growth(%)4.81 
   PAT Growth(%)4.92 
   Total Debt/Equity(x)0.36 
   Current Ratio(x)1.55 
   Quick Ratio(x)1.00 
   Total Debt/Mcap(x)0.08 
More>